|
Growth in the worldwide pharmaceuticals industry is anticipated from the development of new and improved drugs. The industry's landscape would be further metamorphosized by the increasing share of generic pharmaceuticals and evolution of biopharmaceuticals, along with factors such as increasing outsourcing activities related to production and research operations, and compliance with various global trade regulations.
|